Export 197 results:
Filters: Keyword is RNA, Messenger  [Clear All Filters]
Michaud A, Boulet MMichèle, Veilleux A, Noël S, Paris G, Tchernof A. Abdominal subcutaneous and omental adipocyte morphology and its relation to gene expression, lipolysis and adipocytokine levels in women. Metabolism. 2014;63(3):372-81.
Poulin J-F, Laforest S, Drolet G. Enkephalin downregulation in the nucleus accumbens underlies chronic stress-induced anhedonia. Stress. 2014;17(1):88-96.
Bérubé P, Poulin J-F, Laforest S, Drolet G. Enkephalin knockdown in the basolateral amygdala reproduces vulnerable anxiety-like responses to chronic unpredictable stress. Neuropsychopharmacology. 2014;39(5):1159-68.
Michaud A, Lacroix-Pépin N, Pelletier M, Daris M, Biertho L, Fortier MA, Tchernof A. Expression of genes related to prostaglandin synthesis or signaling in human subcutaneous and omental adipose tissue: depot differences and modulation by adipogenesis. Mediators Inflamm. 2014;2014:451620.
Dorval V, Mandemakers W, Jolivette F, Coudert L, Mazroui R, De Strooper B, Hébert SS. Gene and MicroRNA transcriptome analysis of Parkinson's related LRRK2 mouse models. PLoS One. 2014;9(1):e85510.
Deslauriers J, Desmarais C, Sarret P, Grignon S. Implication of the ERK/MAPK pathway in antipsychotics-induced dopamine D2 receptor upregulation and in the preventive effects of (±)-α-lipoic acid in SH-SY5Y neuroblastoma cells. J Mol Neurosci. 2014;52(3):378-83.
Delay C, Tremblay C, Brochu E, Paris-Robidas S, Emond V, Rajput AH, Rajput A, Calon F. Increased LINGO1 in the cerebellum of essential tremor patients. Mov Disord. 2014;29(13):1637-47.
Morin N, Jourdain VA, Morissette M, Grégoire L, Di Paolo T. Long-term treatment with l-DOPA and an mGlu5 receptor antagonist prevents changes in brain basal ganglia dopamine receptors, their associated signaling proteins and neuropeptides in parkinsonian monkeys. Neuropharmacology. 2014;79:688-706.